The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study
Open accessAbstract
Introduction: An international clinical trial enrolled 174 ambulatory males ≥5 years old with nonsense mutation Duchenne muscular dystrophy (nmDMD). Pretreatment data provide insight into reliability, concurrent validity, and minimal clinically important differences (MCIDs) of the 6‐minute walk test (6MWT) and other endpoints. Methods: Screening and baseline evaluations included the 6‐minute walk distance (6MWD), timed function tests (TFTs), quantitative strength by myometry, the PedsQL, heart rate–determined energy expenditure index, and other exploratory endpoints. Results: The 6MWT proved feasible and reliable in a multicenter context. Concurrent validity with other endpoints was excellent. The MCID for 6MWD was 28.5 and 31.7 meters based on 2 statistical distribution methods. Conclusions: The ratio of MCID to baseline mean is lower for 6MWD than for other endpoints. The 6MWD is an optimal primary endpoint for Duchenne muscular dystrophy (DMD) clinical trials that are focused therapeutically on preservation of ambulation and slowing of disease progression. Muscle Nerve 48: 357–368, 2013
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
Varni, J. W., Seid, M., & Kurtin, P. S. (2001) · Medical Care · doi:10.1097/00005650-200108000-00006 · Cited by 5,131
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
The PedsQL™* 4.0 as a Pediatric Population Health Measure: Feasibility, Reliability, and Validity
Varni, J. W., Burwinkle, T. M., Seid, M., & Skarr, D. (2003) · Ambulatory Pediatrics · doi:10.1367/1539-4409(2003)003<0329:tpaapp>2.0.co;2 · Cited by 2,324
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70271-6 · Cited by 2,053
Self-citationDeyo, R. A., Diehr, P., & Patrick, D. L. (1991) · Controlled Clinical Trials · doi:10.1016/s0197-2456(05)80019-4 · Cited by 1,364
Defining clinically meaningful change in health-related quality of life
Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00044-1 · Cited by 1,332
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70272-8 · Cited by 1,172
Self-citationPTC124 targets genetic disorders caused by nonsense mutations
Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S., et al. (2007) · Nature · doi:10.1038/nature05756 · Cited by 1,137
Self-citationVarni, J. W., Limbers, C. A., & Burwinkle, T. M. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-1 · Cited by 1,075
McDonald, C. M., Abresch, R. T., Carter, G. T., Fowler, W. M., Johnson, E. R., Kilmer, D. D., & Sigford, B. J. (1995) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-199509001-00003 · Cited by 1,069
Self-citationde Vet, H. C., Terwee, C. B., Ostelo, R. W., Beckerman, H., Knol, D. L., & Bouter, L. M. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-54 · Cited by 829
Evidence-based path to newborn screening for Duchenne muscular dystrophy
Mendell, J. R., Shilling, C., Leslie, N. D., Flanigan, K. M., al‐Dahhak, R., Gastier‐Foster, J., Kneile, K., Dunn, D. M., Duval, B., Aoyagi, A., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23528 · Cited by 813
Deyo, R. A., & Centor, R. M. (1986) · Journal of Chronic Diseases · doi:10.1016/0021-9681(86)90038-x · Cited by 792
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease
van der Ploeg, A. T., Clemens, P. R., Corzo, D., Escolar, D. M., Florence, J., Groeneveld, G. J., Herson, S., Kishnani, P. S., Laforet, P., Lake, S. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909859 · Cited by 745
Self-citationSystemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Goemans, N. M., Tulinius, M., van den Akker, J. T., Burm, B. E., Ekhart, P. F., Heuvelmans, N., Holling, T., Janson, A. A., Platenburg, G. J., Sipkens, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011367 · Cited by 678
Six-Minute Walk Test in Children and Adolescents
Geiger, R., Strasak, A., Treml, B., Gasser, K., Kleinsasser, A., Fischer, V., Geiger, H., Loeckinger, A., & Stein, J. I. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.12.052 · Cited by 653
Kinali, M., Arechavala-Gomeza, V., Feng, L., Cirak, S., Hunt, D., Adkin, C., Guglieri, M., Ashton, E., Abbs, S., Nihoyannopoulos, P., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70211-x · Cited by 653
Muenzer, J., Wraith, J. E., Beck, M., Giugliani, R., Harmatz, P., Eng, C. M., Vellodi, A., Martin, R., Ramaswami, U., Gucsavas-Calikoglu, M., et al. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000232477.37660.fb · Cited by 584
Wyrwich, K. W., Nienaber, N. A., Tierney, W. M., & Wolinsky, F. D. (1999) · Medical Care · doi:10.1097/00005650-199905000-00006 · Cited by 569
Clinical trial in duchenne dystrophy. I. The design of the protocol
Brooke, M. H., Griggs, R. C., Mendell, J. R., Fenichel, G. M., Shumate, J. B., & Pellegrino, R. J. (1981) · Muscle & Nerve · doi:10.1002/mus.880040304 · Cited by 564
Wraith, J. E., Clarke, L. A., Beck, M., Kolodny, E. H., Pastores, G. M., Muenzer, J., Rapoport, D. M., Berger, K. I., Swiedler, S. J., Kakkis, E. D., et al. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.01.046 · Cited by 547
Varni, J. W., Seid, M., Knight, T. S., Uzark, K., & Szer, I. S. (2002) · Journal of Behavioral Medicine · doi:10.1023/a:1014836921812 · Cited by 531
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
Mendell, J. R., Moxley, R. T., Griggs, R. C., Brooke, M. H., Fenichel, G. M., Miller, J. P., King, W., Signore, L., Pandya, S., Florence, J., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202405 · Cited by 520
Self-citationBeaton, D. E., Boers, M., & Wells, G. A. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200203000-00006 · Cited by 513
Crespo, C. J. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440010113015 · Cited by 504
Hays, R. D., & Woolley, J. M. (2000) · PharmacoEconomics · doi:10.2165/00019053-200018050-00001 · Cited by 488
Bois, R. M. D., Weycker, D., Albera, C., Bradford, W. Z., Costabel, U., Kartashov, A., Lancaster, L., Noble, P. W., Sahn, S. A., Szwarcberg, J., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201007-1179oc · Cited by 465
The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy
McDonald, C. M., Henricson, E. K., Han, J. J., Abresch, R. T., Nicorici, A., Elfring, G. L., Atkinson, L., Reha, A., Hirawat, S., & Miller, L. L. (2010) · Muscle & Nerve · doi:10.1002/mus.21544 · Cited by 397
Self-citationYost, K. J., & Eton, D. T. (2005) · Evaluation & the Health Professions · doi:10.1177/0163278705275340 · Cited by 382
Interpretation of treatment changes in 6-minute walk distance in patients with COPD
Puhan, M. A., Mador, M. J., Held, U., Goldstein, R., Guyatt, G. H., & Schünemann, H. J. (2008) · European Respiratory Journal · doi:10.1183/09031936.00140507 · Cited by 373
Duchenne muscular dystrophy: Patterns of clinical progression and effects of supportive therapy
Brooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R., Florence, J., King, W. M., Pandya, S., Robison, J., Schierbecker, J., et al. (1989) · Neurology · doi:10.1212/wnl.39.4.475 · Cited by 353
Self-citationBrooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R., Miller, J. P., & Province, M. A. (1983) · Muscle & Nerve · doi:10.1002/mus.880060204 · Cited by 353
Beenakker, E. A. C., van der Hoeven, J. H., Fock, J. M., & Maurits, N. M. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00193-6 · Cited by 305
Mcdonald, C. M., Henricson, E. K., Abresch, R. T., Florence, J. M., Eagle, M., Gappmaier, E., Glanzman, A. M., PTC124‐GD‐007‐DMD Study Group, Spiegel, R., Barth, J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23902 · Cited by 303
Self-citationGriggs, R. C. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530160047012 · Cited by 279
ENERGY EXPENDITURE INDEX OF WALKING FOR NORMAL CHILDREN AND FOR CHILDREN WITH CEREBRAL PALSY
Rose, J., Gamble, J. G., Burgos, A., Medeiros, J., & Haskell, W. L. (1990) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1990.tb16945.x · Cited by 246
Beaton, D., Bombardier, C., Katz, J. N., Wright, J. G., Wells, G. A., Boers, M., Strand, V., & Shea, B. (2001) · PubMed · Cited by 237
Muenzer, J., Gucsavas-Calikoglu, M., McCandless, S. E., Schuetz, T. J., & Kimura, A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.09.001 · Cited by 223
Gremeaux, V., Troisgros, O., Benaïm, S., Hannequin, A., Laurent, Y., Casillas, J.-M., & Benaïm, C. (2011) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2010.11.023 · Cited by 217
Mazzone, E., Martinelli, D., Berardinelli, A., Messina, S., D’Amico, A., Vasco, G., Main, M., Doglio, L., Politano, L., Cavallaro, F., et al. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.06.014 · Cited by 216
McDonald, C. M., Henricson, E. K., Abresch, R. T., Han, J. J., Escolar, D. M., Florence, J. M., Duong, T., Arrieta, A., Clemens, P. R., Hoffman, E. P., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23807 · Cited by 183
Self-citationFunctional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study
Mazzone, E., Vasco, G., Sormani, M. P., Torrente, Y., Berardinelli, A., Messina, S., D'Amico, A., Doglio, L., Politano, L., Cavallaro, F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab2e · Cited by 177
Muscle pathology and clinical measures of disability in children with cerebral palsy
Rose, J., Haskell, W. L., Gamble, J. G., Hamilton, R. L., Brown, D. A., & Rinsky, L. (1994) · Journal of Orthopaedic Research · doi:10.1002/jor.1100120603 · Cited by 177
The 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations
MCDonald, C. M., Henricson, E. K., Han, J. J., Abresch, R. T., Nicorici, A., Atkinson, L., Elfring, G. L., Reha, A., & Miller, L. L. (2010) · Muscle & Nerve · doi:10.1002/mus.21808 · Cited by 172
Self-citationStuberg, W. A., & Metcalf, W. K. (1988) · Physical Therapy · doi:10.1093/ptj/68.6.977 · Cited by 166
An integrated method to determine meaningful changes in health-related quality of life
Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.004 · Cited by 165
Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort
Dent, K. M., Dunn, D. M., von Niederhausern, A. C., Aoyagi, A., Kerr, L. M., Bromberg, M. B., Hart, K., Tuohy, T. M. F., White, S. J., den Dunnen, J. T., et al. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30617 · Cited by 152
Toward a standard definition of clinically significant change
Jacobson, N., Follette, W., & Revenstorf, D. (1986) · Behavior Therapy · doi:10.1016/s0005-7894(86)80061-2 · Cited by 145
Small changes in six-minute walk distance are important in diffuse parenchymal lung disease
Holland, A. E., Hill, C. J., Conron, M., Munro, P. E., & McDonald, C. F. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.04.024 · Cited by 144
Self-citationRose, J., Gamble, J. G., Medeiros, J., et al. (1989) · PubMed · Cited by 141
Rose, J., Gamble, J. G., Lee, J., Lee, R. H., & Haskell, W. L. (1991) · Journal of Pediatric Orthopaedics · doi:10.1097/01241398-199109000-00002 · Cited by 135
Henricson, E., Abresch, R. T., Han, J. J., Nicorici, A., Keller, E. G., de Bie, E., & McDonald, C. M. (2013) · PLoS Currents · doi:10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06 · Cited by 126
Self-citationRose, J., Gamble, J. G., Medeiros, J. M., Burgos, A. E., & Haskell, W. L. (1989) · Journal of Pediatric Orthopaedics · doi:10.1097/01241398-198905000-00004 · Cited by 125
Intermittent Prednisone Therapy in Duchenne Muscular Dystrophy: A Randomized Controlled Trial
Beenakker, E. A. C., Fock, J. M., Tol, M. J. V., Maurits, N. M., Koopman, H. M., Brouwer, O. F., & van der Hoeven, J. H. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.128 · Cited by 100
Beenakker, E. A. C., Maurits, N. M., Fock, J. M., Brouwer, O. F., & van der Hoeven, J. H. (2005) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2005.06.004 · Cited by 97
Minimal clinically important difference module: summary, recommendations, and research agenda.
Wells, G. A. H., Anderson, J. J., Beaton, D., Bellamy, N., Boers, M., Bombardier, C., Breedveld, F. C., Carr, A., Cranney, A., Dougados, M., et al. (2001) · PubMed · Cited by 72
Fowler, W. M., Abresch, R. T., Aitkens, S. G., Carter, G. T., Johnson, E. R., Kilmer, D. D., McCrory, M. A., & Wright, N. C. (1995) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-199509001-00002 · Cited by 68
Self-citationMcDonald, C. M., McDonald, D. A., Bagley, A. M., Thomas, S. S., Buckon, C. E., Henricson, E., Nicorici, A., & Sussman, M. D. (2010) · Journal of Child Neurology · doi:10.1177/0883073810371509 · Cited by 63
Self-citationPrednisolone in Duchenne muscular dystrophy with imminent loss of ambulation
Pradhan, S., Ghosh, D., Srivastava, N. K., Kumar, A., Mittal, B., Pandey, C. M., & Singh, U. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0212-1 · Cited by 61
Measurement of Isometric Force in Children with and without Duchenne's Muscular Dystrophy
Brussock, C. M., Haley, S. M., Munsat, T. L., & Bernhardt, D. B. (1992) · Physical Therapy · doi:10.1093/ptj/72.2.105 · Cited by 55
Chamberlain, J. S. (2006) · CRC Press eBooks · doi:10.3109/9780849374456 · Cited by 33
The assisted 6‐minute cycling test to assess endurance in children with a neuromuscular disorder
Jansen, M., Jong, M. D., Coes, H. M., Eggermont, F., van Alfen, N., & de Groot, I. J. M. (2012) · Muscle & Nerve · doi:10.1002/mus.23369 · Cited by 32
Hyde, S. A., Steffensen, B. F., Fløytrup, I., Glent, S., Kroksmark, A., Salling, B., Werlauff, U., & Erlandsen, M. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00175-9 · Cited by 22
Cited by
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
Mendell, J. R., Goemans, N., Lowes, L. P., Alfano, L. N., Berry, K., Shao, J., Kaye, E. M., Mercuri, E., & for the Eteplirsen Study Group and Telethon Foundation DMD Italian Network (2016) · Annals of Neurology · doi:10.1002/ana.24555 · Cited by 518
McDonald, C. M., Campbell, C., Torricelli, R. E., Finkel, R. S., Flanigan, K. M., Goemans, N., Heydemann, P., Kaminska, A., Kirschner, J., Muntoni, F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31611-2 · Cited by 452
Self-citationMendell, J. R., Sahenk, Z., Lehman, K., Nease, C., Lowes, L. P., Miller, N. F., Iammarino, M. A., Alfano, L. N., Nicholl, A., Al-Zaidy, S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1484 · Cited by 405
Duchenne and Becker Muscular Dystrophies
Flanigan, K. M. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.05.002 · Cited by 317
Metadata
- Authors
- McDonald, C. M., Henricson, E. K., Abresch, R. T., Florence, J., Eagle, M., Gappmaier, E., Glanzman, A. M., PTC124‐GD‐007‐DMD Study Group, Spiegel, R., Barth, J., Elfring, G., Reha, A., & Peltz, S. W.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2013-07-17
- Volume
- 48
- Issue
- 3
- Pages
- 357-368
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W1951817210
- Cited by
- 354
- References
- 68
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.